Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children’s Oncology Group (COG)-Reference-Cited by-同舟云学术

Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children’s Oncology Group (COG)

Published:2018-02-23 Issue:6 Volume:32 Page:1370-1379
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Gupta Sumit,Devidas Meenakshi,Loh Mignon L.,Raetz Elizabeth A.,Chen Si,Wang Cindy,Brown Patrick,Carroll Andrew J.,Heerema Nyla A.,Gastier-Foster Julie M.,Dunsmore Kimberly P.,Larsen Eric C.,Maloney Kelly W.,Mattano Leonard A.,Winter Stuart S.,Winick Naomi J.,Carroll William L.,Hunger Stephen P.,Borowitz Michael J.,Wood Brent L.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-018-0039-7.pdf

Reference27 articles.

1. Pui CH, Yang JJ, Hunger SP, Pieters R, Schrappe M, Biondi A, et al. Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol. 2015;33:2938–48.

2. Borowitz MJ, Devidas M, Hunger SP, Bowman WP, Carroll AJ, Carroll WL, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children’s Oncology Group study. Blood. 2008;111:5477–85.

3. Borowitz MJ, Wood BL, Devidas M, Loh ML, Raetz EA, Salzer WL, et al. Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children’s Oncology Group study AALL0232. Blood. 2015;126:964–71.

4. Conter V, Bartram CR, Valsecchi MG, Schrauder A, Panzer-Grumayer R, Moricke A, et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of teh AIEOP-BFM ALL 2000 study. Blood. 2010;115:3206–14.

5. Schrappe M, Valsecchi MG, Bartram CR, Schrauder A, Panzer-Grumayer R, Moricke A, et al. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood. 2011;118:2077–84.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comparative Study of RT-PCR, FISH, and Karyotyping for t(9;22) Positive Leukemias, and Their Outcomes in Pediatric Patients in a Low Middle-Income Country (LMIC);2024-06-12

2. Mechanism of action, potency and efficacy: considerations for cell therapies;Journal of Translational Medicine;2024-05-02

3. Significance of CD34-Positive Cells in Children with B-Cell Acute Lymphoblastic Leukemia: A Case-Control Study;Iranian Journal of Pediatric Hematology & Oncology;2024-01-09

4. Measurable Residual Disease Assessment in Pediatric AML;Pediatric Oncology;2024

5. Flow cytometric and cytomorphological definition of remission achievement in children with B-lineage acute lymphoblastic leukemia;Pediatric Hematology/Oncology and Immunopathology;2023-12-20